New England Journal of Medicine· 2016Q1

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors

Babak J. Orandi, Xun Luo, Allan B. Massie, Jacqueline Garonzik‐Wang et al.

352citations
Q1SCImago
2016year

Short summary

Kidney transplant recipients from HLA-incompatible live donors showed a significant survival benefit compared to waiting list controls, with 8-year survival rates of 76.5% vs. 62.9% (deceased donor transplant) and 43.9% (waiting list only).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Transplantation

TransplantationMedicine